Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Tatli, Ali Murat
160  Ergebnisse:
Personensuche X
?
1

Treatment outcomes and prognostic factors in patients with ..:

Kahraman, Seda ; Karakaya, Serdar ; Kaplan, Muhammed Ali...
Scientific Reports.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

A multicenter, retrospective archive study of radiological ..:

Kilickap, Saadettin ; Ozturk, Akin ; Karadurmus, Nuri...
Medicine.  103 (2024)  21 - p. e37972 , 2024
Link: https://doi.org/10.1097/..
 
?
3

Is there any prognostic significance in pleural involvement..:

Güner, Gürkan ; Aktaş, Burak Yasin ; Başal, Fatma Buğdaycı...
Journal of Cancer Research and Clinical Oncology.  149 (2023)  14 - p. 13271-13277 , 2023
Link: https://doi.org/10.1007/..
 
?
4

The effect of concomitant proton pump inhibitor use on surv..:

Uğraklı, Muzaffer ; Koçak, Mehmet Zahid ; Dinç, Gülhan...
Journal of Cancer Research and Clinical Oncology.  149 (2023)  11 - p. 9183-9189 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Tailoring adjuvant chemotherapy by circulating tumor DNA (c..:

Akagündüz, Baran ; Guven, Deniz Can ; Ozer, Muhammet...
Journal of Geriatric Oncology.  14 (2023)  2 - p. 101367 , 2023
Link: https://doi.org/10.1016/..
 
?
6

The effect of concomitant use of proton pump inhibitors wit..:

Çağlayan, Dilek ; Koçak, Mehmet Zahid ; Geredeli, Çağlayan...
European Journal of Clinical Pharmacology.  79 (2022)  2 - p. 243-248 , 2022
Link: https://doi.org/10.1007/..
 
?
7

The percentage of ALK-positive cells and the efficacy of fi..:

Hizal, Mutlu ; Bilgin, Burak ; Paksoy, Nail...
Journal of Cancer Research and Clinical Oncology.  149 (2022)  8 - p. 4141-4148 , 2022
Link: https://doi.org/10.1007/..
 
?
8

Lung Cancer in Turkey:

Cangır, Ayten Kayı ; Yumuk, Perran Fulden ; Sak, Serpil Dizbay...
Journal of Thoracic Oncology.  17 (2022)  10 - p. 1158-1170 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Crizotinib efficacy and safety in patients with advanced NS..:

Gürbüz, Mustafa ; Kiliçkap, Saadettin ; Bilici, Ahmet...
Medicine.  101 (2022)  50 - p. e32368 , 2022
Link: https://doi.org/10.1097/..
 
?
10

Atezolizumab combined with chemotherapy in the first-line t..:

Gürbüz, Mustafa ; Kutlu, Yasin ; Akkuş, Erman...
Journal of Cancer Research and Clinical Oncology.  148 (2022)  12 - p. 3547-3555 , 2022
Link: https://doi.org/10.1007/..
 
?
11

Real-life comparison of afatinib and erlotinib in non-small..:

Gursoy, Pınar ; Tatli, Ali Murat ; Erdem, Dilek...
Journal of Cancer Research and Clinical Oncology.  149 (2022)  2 - p. 865-875 , 2022
Link: https://doi.org/10.1007/..
 
?
12

Real-life comparison of the afatinib and first-generation t..:

Bilgin, Burak ; Sendur, Mehmet Ali Nahit ; Yucel, Sebnem...
Journal of Cancer Research and Clinical Oncology.  147 (2021)  7 - p. 2145-2152 , 2021
Link: https://doi.org/10.1007/..
 
?
13

The real-life efficacy and safety of osimertinib in pretrea..:

Hizal, Mutlu ; Bilgin, Burak ; Paksoy, Nail...
Journal of Cancer Research and Clinical Oncology.  148 (2021)  6 - p. 1501-1508 , 2021
Link: https://doi.org/10.1007/..
 
?
14

Cetuximab-induced rash is associated with overall survival ..:

Göksu, Sema Sezgin ; Tatlı, Ali Murat ; Geredeli, Çağlayan...
Cancer Chemotherapy and Pharmacology.  88 (2021)  5 - p. 805-812 , 2021
Link: https://doi.org/10.1007/..
 
?
15

Comparison of two different carboplatin and weekly paclitax..:

Kıvrak Salim, Derya ; Akın Telli, Tuğba ; Tatlı, Ali Murat..
Cancer Chemotherapy and Pharmacology.  83 (2019)  6 - p. 1137-1145 , 2019
Link: https://doi.org/10.1007/..
 
1-15